Phibro Animal Health Co. (NASDAQ:PAHC – Free Report) – Equities researchers at Zacks Research lifted their Q3 2025 earnings estimates for Phibro Animal Health in a report released on Wednesday, April 9th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $0.51 for the quarter, up from their previous forecast of $0.50. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q4 2025 earnings at $0.52 EPS, FY2025 earnings at $1.92 EPS, Q2 2026 earnings at $0.57 EPS, FY2026 earnings at $1.97 EPS, Q2 2027 earnings at $0.57 EPS and FY2027 earnings at $2.23 EPS.
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.
Read Our Latest Stock Analysis on PAHC
Phibro Animal Health Stock Performance
Shares of PAHC stock opened at $19.06 on Thursday. Phibro Animal Health has a one year low of $12.30 and a one year high of $26.55. The firm’s 50 day moving average price is $22.37 and its 200-day moving average price is $22.52. The firm has a market cap of $771.99 million, a P/E ratio of 39.71, a P/E/G ratio of 0.45 and a beta of 0.63. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20.
Phibro Animal Health Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th were given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio (DPR) is 100.00%.
Hedge Funds Weigh In On Phibro Animal Health
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Sterling Capital Management LLC lifted its position in Phibro Animal Health by 2.4% in the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock worth $394,000 after purchasing an additional 448 shares during the period. Rhumbline Advisers lifted its position in Phibro Animal Health by 0.6% in the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock worth $1,608,000 after purchasing an additional 484 shares during the period. Los Angeles Capital Management LLC lifted its position in Phibro Animal Health by 2.1% in the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock worth $505,000 after purchasing an additional 503 shares during the period. BNP Paribas Financial Markets lifted its position in Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after purchasing an additional 729 shares during the period. Finally, New York State Teachers Retirement System lifted its holdings in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after acquiring an additional 775 shares during the period. Institutional investors and hedge funds own 99.34% of the company’s stock.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Articles
- Five stocks we like better than Phibro Animal Health
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 5 Highest-Rated Dividend Stocks According to MarketBeat
- With Risk Tolerance, One Size Does Not Fit All
- Levi’s Stock Gains Momentum With DTC Turnaround
- Where to Find Earnings Call Transcripts
- 3 Robotics Stocks That Could Benefit From U.S. Manufacturing Boom
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.